Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1

被引:0
|
作者
Mei Ye
Ruigang Han
Jianwu Shi
Xunda Wang
Allan Z. Zhao
Fanghong Li
Hao Chen
机构
[1] Guangdong University of Technology,School of Biomedical and Pharmaceutical Sciences
[2] Reproductive Medicine Center of The 306th Hospital of PLA,Institute of Reproductive Medicine, Medical School of Nantong University
[3] Nantong University,undefined
来源
Medical Oncology | 2020年 / 37卷
关键词
CAS; Breast cancer; Cell proliferation;
D O I
暂无
中图分类号
学科分类号
摘要
Breast cancer is the most common cancer in women. Although several studies demonstrated cellular apoptosis susceptibility protein (CAS) involved in the development of breast cancer, the underlying mechanisms of CAS regulating cell processes in the breast cancer remain elusive. In the present study, we explored the possible mechanism of CAS in contributing to the cell proliferation in the breast cancer cell line MCF-7. Knockdown of CAS led to the reduction of cell viability and proliferation. Furthermore, cell cycle was arrested in G0/G1 phase after knocking down CAS with the decrease of cyclinD1. In addition, RNA-seq analysis for the CAS knockdown cells demonstrated that total eleven genes were significantly altered (Fold changes > 2). Of note, the expression of cyp24a1 was dramatically increased in the shCAS cells compared to that of shNC cells as well as confirmed by quantitative real-time polymerase chain reaction (qPCR). These observations clarified the previous conflicting results on the cell fates of the breast cells regulated by CAS and provide new insight into the role of CAS in the development of breast cancer.
引用
收藏
相关论文
共 50 条
  • [1] Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1
    Ye, Mei
    Han, Ruigang
    Shi, Jianwu
    Wang, Xunda
    Zhao, Allan Z.
    Li, Fanghong
    Chen, Hao
    MEDICAL ONCOLOGY, 2020, 37 (05)
  • [2] CSEIL/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells
    Liao, Ching-Fong
    Luo, Shue-Fen
    Li, Li-Tzu
    Lin, Chuang-Yu
    Chen, Ying-Chun
    Jiang, Ming-Chung
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2008, 27 (1)
  • [3] CYP24A1 polymorphisms and breast cancer risk
    Beuy Joob
    Viroj Wiwanitkit
    Breast Cancer Research and Treatment, 2020, 180 : 525 - 525
  • [4] CYP24A1 polymorphisms and breast cancer risk
    Joob, Beuy
    Wiwanitkit, Viroj
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 525 - 525
  • [5] Implication of CYP24A1 Splicing in Breast Cancer
    Scheible, Chimi
    Thill, Marc
    Baum, Sascha
    Solomayer, Erich
    Friedrich, Michael
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (01) : 109 - 114
  • [6] CSE1L/CAS, the cellular apoptosis susceptibility protein, enhances invasion and metastasis but not proliferation of cancer cells
    Ching-Fong Liao
    Shue-Fen Luo
    Li-Tzu Li
    Chuang-Yu Lin
    Ying-Chun Chen
    Ming-Chung Jiang
    Journal of Experimental & Clinical Cancer Research, 27
  • [7] Low CYP24A1 mRNA expression and its role in prognosis of breast cancer
    Hongqiao Cai
    Yan Jiao
    Yanqing Li
    Zhaoying Yang
    Miao He
    Yahui Liu
    Scientific Reports, 9
  • [8] Low CYP24A1 mRNA expression and its role in prognosis of breast cancer
    Cai, Hongqiao
    Jiao, Yan
    Li, Yanqing
    Yang, Zhaoying
    He, Miao
    Liu, Yahui
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Local production of active vitamin D3 metabolites in breast cancer cells by CYP24A1 and CYP27B1
    Dennis, Cydney
    Dillon, Jonathan
    Cohen, David J.
    Halquist, Matthew S.
    Pearcy, Adam C.
    Schwartz, Zvi
    Boyan, Barbara D.
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 232
  • [10] Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer
    Ioannis A. Voutsadakis
    Molecular Biology Reports, 2020, 47 : 9821 - 9830